|

The Women's Screening and Self-Testing Program (PROMETA) Study

RECRUITINGN/ASponsored by Tulane University
Actively Recruiting
PhaseN/A
SponsorTulane University
Started2026-07-13
Est. completion2028-06-30
Eligibility
Age25 Years – 49 Years
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06810739

Summary

This proposal directly addresses the ability to safely scale-up a Screen-Triage-Treat approach to cervical cancer screening. The investigators propose to capitalize on a pool of screen-eligible women accessing routine care within targeted human immunodeficiency virus (HIV) care and treatment services. The primary outcome of interest is the number of women screened and the proportion of screen-positive women undergoing treatment. Secondary outcomes will focus on other implementation outcomes, and if successful, will be utilized to inform future research to take this approach to scale across Mozambique.

Eligibility

Age: 25 Years – 49 YearsSex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

* Women 25-49 years
* Accessing HIV care and treatment services
* Not being pregnant
* Patients with a cervix

Exclusion Criteria:

* Physical or mental impairment that inhibits participation in the study
* Pregnant women or \<6 weeks post-partum
* Women who have undergone a total hysterectomy with removal of the cervix

Conditions2

CancerHuman Papilloma Virus Related Cervical Carcinoma

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.